AssetMark Inc’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
Other funds holding LFCR
NIMC
WC
WC
HA
AssetMark Inc's LFCR Position: Q2 2019 in Review
AssetMark Inc sold out of Lifecore Biomedical (LFCR) in Q2 2019, closing a stake of 6 shares.
AssetMark Inc first reported a position in LFCR in Q3 2013 and held it in 23 quarters. The position peaked at $986K in Q4 2014. 99 funds tracked by Wall St. Rank hold LFCR as of Q2 2019.
- AssetMark Inc reported no remaining Lifecore Biomedical position as of Q2 2019 after selling out during the quarter.
- AssetMark Inc sold 6 Lifecore Biomedical shares in Q2 2019.
- AssetMark Inc first reported a position in Lifecore Biomedical in Q3 2013 and held it in 23 quarters.
- AssetMark Inc's Lifecore Biomedical position peaked at $986K in Q4 2014.
- 99 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2019.
Based on AssetMark Inc's 13F filing for Q2 2019, filed 14 Aug 2019.